Analyst Ranking
Bottom 2%
#4665 out of 4753 analysts
Average Return
-7.48%
Win Rate
26%48 out of 183
Risk vs Reward
Poor
Good

Vernon Bernardino's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Novavax IncNVAX
+1,416.85%$11.75$178.23
2020-03-25 -
2021-03-25
Buy
Candel Therapeutics IncCADL
+626.04%$1.69$12.27
2023-05-22 -
2024-05-21
Buy
Cassava Sciences IncSAVA
+435.96%$9.76$52.31
2020-09-23 -
2021-09-22
Buy
Candel Therapeutics IncCADL
+391.21%$0.91$4.47
2023-11-13 -
2024-11-12
Buy
Eledon Pharmaceuticals IncELDN
+301.67%$1.20$4.82
2023-11-13 -
2024-11-12
Buy

Vernon Bernardino's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Cassava Sciences IncSAVA
15Hold$116.00+3,267.20%Downgrades
7 days ago
Nrx Pharmaceuticals IncNRXP
4Buy$19.00+1,307.41%Reiterates
8 days ago
Eledon Pharmaceuticals IncELDN
9Buy$16.00+266.13%Reiterates
13 days ago
Geovax Labs IncGOVX
13Buy$8.00+216.21%Reiterates
13 days ago
Cardiol Therapeutics IncCRDL
6Buy$9.00+473.25%Reiterates
13 days ago
Humacyte IncHUMA
4Buy$12.00+169.66%Reiterates
15 days ago
Candel Therapeutics IncCADL
4Buy$11.00+140.70%Reiterates
15 days ago
Senseonics Holdings IncSENS
8Buy$2.00+543.09%Reiterates
18 days ago
Aethlon Medical IncAEMD
6Buy$7.00+1,632.67%Reiterates
18 days ago
Dyadic International IncDYAI
7Buy$6.00+252.94%Reiterates
19 days ago
Novavax IncNVAX
17Buy$19.00+116.65%Reiterates
20 days ago
Artelo Biosciences IncARTL
8Buy$5.00+367.29%Reiterates
20 days ago
Citius Pharmaceuticals IncCTXR
9Buy$100.00+3,005.59%Reiterates
21 days ago
Can Fite Biopharma LtdCANF
5Buy$18.00+729.49%Reiterates
21 days ago
Edesa Biotech IncEDSA
9Buy$21.00+786.08%Reiterates
3 months ago
Phio Pharmaceuticals CorpPHIO
5Buy$36.00+1,132.88%Reiterates
7 months ago
Enveric Biosciences IncENVB
1Buy$10.00+2,948.78%Initiates Coverage On
10 months ago
Windtree Therapeutics IncWINT
1Hold$18.00+3,214.92%Initiates Coverage On
a year ago
Moleculin Biotech IncMBRX
1Buy$45.00+1,572.86%Initiates Coverage On
a year ago
Gamida Cell LtdGMDAQ
7Buy$5.00N/AMaintains
a year ago
Aridis Pharmaceuticals IncARDS
6Buy$2.00N/AReiterates
a year ago
Aytu Biopharma IncAYTU
4Buy$20.00N/AReiterates
2 years ago
Tff Pharmaceuticals IncTFFP
2Buy$100.00N/AMaintains
2 years ago
Finch Therapeutics Group IncFNCH
3Buy$210.00N/AReiterates
2 years ago
Onconetix IncONCO
3Buy$9.00N/AMaintains
2 years ago
Acer Therapeutics IncACER
1Buy$12.00N/AReiterates
2 years ago
Seres Therapeutics IncMCRB
5Buy$25.00N/AReiterates
2 years ago
Vtv Therapeutics IncVTVT
4Buy$240.00N/AReiterates
2 years ago
Dominari Holdings IncDOMH
2Buy$16.00N/AMaintains
2 years ago
Aptorum Group LtdAPM
1Buy$80.00N/AInitiates Coverage On
2 years ago
Endra Life Sciences IncNDRA
2Buy$175,000.00N/AMaintains
3 years ago
Catheter Precision IncVTAK
1Buy$600.00N/AInitiates Coverage On
3 years ago
Predictive Oncology IncPOAI
1Buy$100.00N/AInitiates Coverage On
3 years ago
Tenax Therapeutics IncTENX
1Buy$8,000.00N/AInitiates Coverage On
4 years ago
Geron CorpGERN
1Buy$7.00N/AMaintains
4 years ago
Inspiremd IncNSPR
1Buy$30.00N/AReiterates
5 years ago
Navidea Biopharmaceuticals IncNAVB
1Buy$4.00N/AReiterates
5 years ago
Achieve Life Sciences IncACHV
1Buy$40.00N/AInitiates Coverage On
5 years ago
Cel Sci CorpCVM
1Buy$18.00N/AInitiates Coverage On
5 years ago
Galectin Therapeutics IncGALT
1Buy$5.00N/AInitiates Coverage On
7 years ago
Evoke Pharma IncEVOK
1Buy$1,440.00N/AInitiates Coverage On
7 years ago
Cytokinetics IncCYTK
1Buy$24.00N/AInitiates Coverage On
7 years ago
Galmed Pharmaceuticals LtdGLMD
1Buy$3,420.00N/AInitiates Coverage On
7 years ago
Intercept Pharmaceuticals IncICPT
1Buy$136.00N/AInitiates Coverage On
7 years ago
Aveo Pharmaceuticals IncAVEO
1Buy$7.00N/AInitiates Coverage On
7 years ago
Pluri IncPLUR
1Buy$5.00N/AInitiates Coverage On
7 years ago
Redhill Biopharma LtdRDHL
1Buy$19,000.00N/AInitiates Coverage On
7 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.